ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 125 participants.

Also called NCT06167213

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 125 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06167213
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06167213. Non-randomized; no masking; primary purpose treatment. Start 2027-01 (anticipated); primary completion 2029-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
Condition
Mitral Regurgitation
Condition
Mitral Valve Disease
Condition
Mitral Stenosis
Intervention (Device)
SAPIEN X4 THV
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct06167213
Content hash
f1814ac978613d796a669136741949a26cf8da026988b36960df2143548577dd